Adult Oligodendroglial Tumor — Trials

Adult Oligodendroglial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01478321	Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas	terminated	Phase 2	54	Northwestern UniversityOTHER	1	Mar 12, 2020	clinicaltrials
NCT00003472	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma	terminated	Phase 2	13	Burzynski Research InstituteOTHER	1	Mar 21, 2018	clinicaltrials
NCT01189240	RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma	terminated	Phase 1 / Phase 2	13	National Cancer Institute (NCI)NIH	1	Dec 14, 2015	clinicaltrials

Data updated 22 days agoSource updated Mar 12, 2020source: clinicaltrials